GSK plc
$163.78B- Market cap
- $107.67B
- Debt
- +$44.87B
- Cash
- −$3.40B
Capital structure 71% equity / 29% debt · EV / Revenue 3.71x · EV / EBITDA 19.25x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
GSK · current priceP/E 13.07x
$49.90Latest market snapshot
Implied fair value · at KALU's multiple
$92.6285.6% above market
3.82 GSK EPS (TTM)×24.26x KALU P/E=$92.62
Market $49.90Implied $92.62
KALU · current priceP/E 24.26x
$164.22Latest market snapshot
Implied fair value · at GSK's multiple
$88.4846.1% below market
6.77 KALU EPS (TTM)×13.07x GSK P/E=$88.48
Market $164.22Implied $88.48